ALB and sarcoma: Indeed, researchers also found that combination use of different serum inflammation markers, such as Glasgow Prognostic Score (GPS), neutrophil/lymphocyte ratio (NLR) and C-reactive protein/Albumin Ratio (CAR), could predict prognosis of sarcoma patients [18, 24, 48, 49], highlighting the import of sarcoma-associated inflammation responses.